THE EFFECTIVENESS OF EARLY ANTIVIRAL THERAPY IN REDUCING COVID-19 SEVERITY
Abstract
The global outbreak of COVID-19 has led to a critical need for effective therapeutic strategies. Among these, early administration of antiviral agents such as remdesivir and molnupiravir has shown potential to reduce disease severity and improve clinical outcomes. This study investigates the clinical impact of initiating antiviral therapy during the early phase of SARS-CoV-2 infection, focusing on hospitalization rates, ICU admissions, and mortality.
Fields of Study & Subjects
COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research
Respiratory viral infections research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026
- Document type
- Dataset